About Signity Pharmaceuticals Private Limited
Data last updated:
Signity Pharmaceuticals Private Limited is a private limited company based in Nagpur, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 September 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74900MH2010PTC207591. Its GSTIN is 27AAPCS1435D1ZE (Maharashtra).
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹64.94 Lakh. It is led by directors including Bhupendra Bhaskar Marliwar and Saiye Bhupendra Marliwar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Nagpur, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹15.55 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹40.06 Lakh (net margin 2.6%) and EBITDA of ₹84.09 Lakh (EBITDA margin 5.4%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 17% over five years.
The company has about 45 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Signity Pharmaceuticals. As per MCA filings, the company has open charges of ₹4 Cr on record. Court records list 8 cases involving the company, including 8 filed by the company; 4 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website signitypharma.com.
Company details
Contact details
Signity Pharmaceuticals Private Limited's registered office is in Nagpur, Maharashtra. Its website is signitypharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No.10 Ground Floor Dnyanyog Apartment, Deo Nagar Khamla Road, Nagpur, Maharashtra, India – 440015
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Signity Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Signity Pharmaceuticals operates one associated brand: Signity Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures high-end anti-infectives, nutraceuticals, and life-saving drugs for global markets. | signitypharma.com |
Business activity
The main business activity of Signity Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Signity Pharmaceuticals Private Limited, buy the company report.
Financials of Signity Pharmaceuticals Private Limited
FY 2025 filings availableSignity Pharmaceuticals Private Limited reported revenue of ₹15.55 Cr (up 7% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 17% over five years, including 7% growth in the latest year. EBITDA rose 15% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹84.09 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹40.06 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.4% | ||||
| Net Profit Margin | 2.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Signity Pharmaceuticals Private Limited, buy the company report.
Board of directors of Signity Pharmaceuticals Private Limited
Signity Pharmaceuticals has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bhupendra Bhaskar Marliwar | Director | 13 Sep 2010 | 16 Years 1 Months | Current |
| Saiye Bhupendra Marliwar | Additional Director | 19 Jul 2025 | 1 Years 3 Months | Current |
| Bhraman Bhaskar Marliwar Also directs: Tara Lifescience Private Limited | Additional Director | 19 Jul 2025 | 1 Years 3 Months | Current |
| Bhushan Bhaskar Marliwar | Additional Director | 22 Aug 2025 | 1 Years 2 Months | Current |
Auditor
Signity Pharmaceuticals Private Limited is audited by AGRAWAL BUDHRAJA AND ASSOCTAES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AGRAWAL BUDHRAJA AND ASSOCTAES | FY 2023 | 100124W |
Shareholding
The shareholding of Signity Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Signity Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 11 Sep 2025 | 101158725 | Others | ₹4 Cr | Open |
To see the full charge records of Signity Pharmaceuticals Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
Signity Pharmaceuticals Private Limited has 8 court cases on record: 8 filed by Signity Pharmaceuticals. 4 cases are pending and 4 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 8 | 0 | 4 |
Cases on record (5 of 8)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Nagpur, Maharashtra | Court case (Sum.Civ.Suit) | Filed by the company against an individual | Pending |
| District court, Nagpur, Maharashtra | Court case (Sum.Civ.Suit) | Filed by the company against an individual | Pending |
| District court, Nagpur, Maharashtra | Court case (Sum.Civ.Suit) | Filed by the company against Apex Pharmacy Through Its Proprietor Saurabh Meghani | Pending |
| District court, Nagpur, Maharashtra | Court case (Sum.Civ.Suit) | Filed by the company against Navoday Pharmacy Through Its Proprietor Jaiprakash Chaurasia | Pending |
| District court, Nagpur, Maharashtra | Civil suit | Filed by the company against M/S Ganpati Medicare Stores | Disposed |
To see the full case history of Signity Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Signity Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Signity Pharmaceuticals Private Limited has a workforce of 45 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.
GST
Signity Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAPCS1435D1ZE | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Signity Pharmaceuticals Private Limited, buy the company report.
Recent activity
Signity Pharmaceuticals Private Limited has 7 board changes on record since 2010: 5 appointments and 2 cessations. The latest: Bhushan Bhaskar Marliwar was appointed as Additional Director on 22 Aug 2025.
Frequently asked questions
Signity Pharmaceuticals is an active private limited company based in Nagpur, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 13 September 2010 (16+ years old) and is registered under CIN U74900MH2010PTC207591.
Signity Pharmaceuticals has 4 current directors:
- Bhupendra Bhaskar Marliwar - Director
- Saiye Bhupendra Marliwar - Additional Director
- Bhraman Bhaskar Marliwar - Additional Director
- Bhushan Bhaskar Marliwar - Additional Director
The latest financial statements of Signity Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Signity Pharmaceuticals is 27AAPCS1435D1ZE, registered in Maharashtra.
The CIN (Corporate Identification Number) of Signity Pharmaceuticals is U74900MH2010PTC207591. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Signity Pharmaceuticals has 8 court cases on record: 8 filed by the company. 4 are pending.
Signity Pharmaceuticals was incorporated on 13 September 2010, making it 16+ years old. It is registered with the Registrar of Companies, Mumbai.
Bhushan Bhaskar Marliwar was appointed as Additional Director on 22 Aug 2025. Bhraman Bhaskar Marliwar was appointed as Additional Director on 19 Jul 2025. Saiye Bhupendra Marliwar was appointed as Additional Director on 19 Jul 2025. Signity Pharmaceuticals has 7 board changes on record in total.
Signity Pharmaceuticals can be reached through the website signitypharma.com. Its registered office is in Nagpur, Maharashtra, India.
The registered office of Signity Pharmaceuticals is at Plot No.10 Ground Floor Dnyanyog Apartment, Deo Nagar Khamla Road, Nagpur, Maharashtra, India – 440015.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
